Ginkgo Bioworks Overview

  • Founded
  • 2008
Founded
  • Status
  • Private
  • Employees
  • 350
Employees
  • Latest Deal Type
  • Series E
  • Latest Deal Amount
  • $70M
Latest Deal Amount
  • Investors
  • 46

Ginkgo Bioworks General Information

Description

Developer of a cell programming platform intended to make biology easier to engineer. The company's platform offers probiotic bacteria to protect the body from dangerous infections to generate libraries of molecules and also discover molecules in flavors, sweeteners, cosmetic ingredients, crop treatments, and pharmaceuticals, enabling clients to scale the process of organism engineering using software and hardware automation.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Primary Office
  • 27 Drydock Avenue
  • 8th Floor
  • Boston, MA 02210
  • United States
+1 (877) 000-0000

Ginkgo Bioworks Timeline

2017201820192020
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Ginkgo Bioworks Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Later Stage VC (Series E) 15-May-2020 $70M 00000 00.000 Completed Generating Revenue
12. Secondary Transaction - Private 00000 Completed Generating Revenue
11. Later Stage VC (Series E) 19-Sep-2019 00000 00000 00.000 Completed Generating Revenue
10. Later Stage VC (Series D) 13-Dec-2017 00000 00000 00.000 Completed Generating Revenue
9. Accelerator/Incubator 20-Jun-2017 00000 Completed Generating Revenue
8. Later Stage VC (Series C) 08-Jun-2016 00000 00000 00000 Completed Generating Revenue
7. Debt - General 05-Oct-2015 000.00 Completed Generating Revenue
6. Later Stage VC (Series B) 08-Jul-2015 000.00 000.00 00000 Completed Generating Revenue
5. Later Stage VC (Series A) 18-Mar-2015 $9M $9.1M Completed Generating Revenue
4. Grant 01-Jan-2015 $15M $120K Completed Generating Revenue
To view Ginkgo Bioworks’s complete valuation and funding history, request access »

Ginkgo Bioworks Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series E 0,000,000 00.000000 0000.00 0000.00 00 0000.00 0.000
Series D 0,000,000 00.000000 000.00 000.00 00 000.00 00.000
Series C 4,658,503 $0.010000 $21.23 $21.23 1x $21.23 14.4%
Series B 4,143,251 $0.010000 $12.83 $12.83 1x $12.83 12.8%
To view Ginkgo Bioworks’s complete cap table history, request access »

Ginkgo Bioworks Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a cell programming platform intended to make biology easier to engineer. The company's platform offers prob
Biotechnology
Boston, MA
350 As of 2020
00000
0.000 0000-00-00
00000000000 00000

000 0000

voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non p
0000000000000
France
00000
0000 0000-00-00
00000000000 00000

00000000

at. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla par
0000000000000
Warren, NJ
00 As of 0000
00000
00.00 0000-00-00
000000&0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Ginkgo Bioworks Competitors (21)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
DNA Script Venture Capital-Backed France 00000 00000000000 00000
00000000 0000 Formerly VC-backed Warren, NJ 00 00000 000000&0 00000
00000000 Venture Capital-Backed Berkeley, CA 00 0000 00000000000 0000
000000000 00000000 Venture Capital-Backed San Diego, CA 00 000.00 0000000000 0 000.00
00000000000 000000 Venture Capital-Backed Vancouver, Canada 00 0000 000000000000 0000
You’re viewing 5 of 21 competitors. Get the full list »

Ginkgo Bioworks Executive Team (12)

Name Title Board Seat Contact Info
Jason Kelly Ph.D Co-Founder, Chief Executive Officer & Board Member
Zach Smith Director, Business Development
Ena Cratsenburg Chief Business Officer
Peter Boynton Chief Commercial Officer
Austin Che Ph.D Co-Founder
You’re viewing 5 of 12 executive team members. Get the full list »

Ginkgo Bioworks Board Members (3)

Name Representing Role Since
Christian Henry Self Board Member 000 0000
Jason Kelly Ph.D Ginkgo Bioworks Co-Founder, Chief Executive Officer & Board Member 000 0000
Marijn Dekkers Ph.D Self Chairman 000 0000
To view Ginkgo Bioworks’s complete board members history, request access »

Ginkgo Bioworks Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ginkgo Bioworks Investors (46)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Illumina Corporation Minority 000 0000 000000 0
MicroVentures Venture Capital Minority 000 0000 000000 0
Novalis LifeSciences PE/Buyout Minority 000 0000 000000 0
T. Rowe Price Asset Manager Minority 000 0000 000000 0
VC23 Investors Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 46 investors. Get the full list »

Ginkgo Bioworks Investments & Acquisitions (8)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 11-Jun-2019 0000 0000 Drug Discovery 00000 00000 00.0
0000 00000 000 (00 15-May-2019 000000000000000000 Biotechnology 00000 00000 00.0
0000000000 0000000 31-Jan-2019 000000000000000000 Other Commercial Products 00000 00000 00.0
00000000 08-Nov-2018 000000000000000000 0000 Biotechnology 00000 00000 00.0
Genomatica 05-Oct-2018 Later Stage VC 0000 Multi-line Chemicals 00000 00000 00.0
You’re viewing 5 of 8 investments and acquisitions. Get the full list »

Ginkgo Bioworks Subsidiaries (1)

Company Name Industry Location Founded
00000000 Biotechnology Woburn, MA 0000
To view Ginkgo Bioworks’s complete subsidiaries history, request access »

Ginkgo Bioworks Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000000 11-Jun-2019 0000 0000 Completed
  • 000000 00000000
To view Ginkgo Bioworks’s complete exits history, request access »